MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$101,695K
EPS
-$1.9
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
76,996
General and administrative
23,850
Impairment charge
3,175
Total operating expenses
104,021
Loss from operations
-104,021
Interest income
3,964
Interest expense
1,602
Other income (expense), net
-36
Loss before income taxes
-101,695
Income tax provision
0
Net loss
-101,695
Basic EPS
-1.9
Diluted EPS
-1.9
Basic Average Shares
53,658,399
Diluted Average Shares
53,658,399
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$101,695K Loss before incometaxes-$101,695K Interest income$3,964K Loss from operations-$104,021K Interest expense$1,602K Other income(expense), net-$36K Total operatingexpenses$104,021K Research and development$76,996K General andadministrative$23,850K Impairment charge$3,175K

ALX ONCOLOGY HOLDINGS INC (ALXO)

ALX ONCOLOGY HOLDINGS INC (ALXO)